A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Two Sigma Advisers, LP holds 10,800 shares of HCM stock, worth $187,488. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,800
Previous 11,200 3.57%
Holding current value
$187,488
Previous $191,000 10.47%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$16.03 - $20.31 $6,412 - $8,123
-400 Reduced 3.57%
10,800 $211,000
Q2 2024

Aug 14, 2024

BUY
$16.36 - $21.78 $183,232 - $243,936
11,200 New
11,200 $191,000

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.